Prosecutors said Friday they have indicted Medytox CEO Jung Hyun-ho on charges of unlawfully manufacturing and distributing Meditoxin, a botulinum toxin product. Still, they allowed him to stand trial without physical detention.
The public prosecutors' office in Cheongju, North Chungcheong Province, said it charged Chung with violating the Pharmaceutical Affairs Act and the obstruction of justice.
The prosecution said Chung led Medytox to produce the BTX product from unauthorized raw materials from December 12 to May 2013 and manipulated the raw material information and titer test results to obtain the approval from the Ministry of Food and Drug Safety on 28 occasions to export 145,395 vials of the product.
Besides, Chung is accused of getting the regulator’s shipment approval by fabricating titer test results on Meditoxin on 15 times from October 2012 to November 2014 to export 67,505 vials, and 40 times from April to June 2015 to export 191,374 vials. He also manufactured and sold the pharmaceutical product that violated the approval criteria, the prosecutors said.
The prosecution also arrested the head of the Medytox’s plant for the same charges, indicted him, and notified the alleged crimes to the food and drug safety ministry.
<© Korea Biomedical Review, All rights reserved.>